Department of Surgery, Cancer Centre, University Medical Centre, Utrecht, The Netherlands
Department of Surgery, Cancer Centre, University Medical Centre, Utrecht, The Netherlands.
BMJ Open. 2022 Jul 7;12(7):e058389. doi: 10.1136/bmjopen-2021-058389.
Patients with COVID-19 may be asymptomatic and are able to transmit COVID-19 during a surgical procedure, resulting in increased pressure on healthcare and reduced control of COVID-19 spread. There remains uncertainty about the implementation of preoperative screening for COVID-19 in asymptomatic surgical patients. Therefore, this study aims to determine the prevalence of preoperative COVID-19, confirmed by reverse transcriptase PCR (RT-PCR), in asymptomatic patients.
Systematic review and meta-analysis.
Pubmed and Embase databases were searched through 20 February 2022.
All COVID-19 articles including preoperative asymptomatic patients were included.
Two independent reviewers extracted data and assessed risk of bias. Meta-analysis was performed to determine the prevalence of COVID-19 with 95% CI. Moreover, estimated positive predictive value (PPV), negative predictive value, false-positives (FP) and false-negatives were calculated for preoperative asymptomatic patients.
Twenty-seven studies containing 27 256 asymptomatic preoperative screened patients were included, of which 431 were positive for COVID-19 by RT-PCR test. In addition, the meta-analysis revealed a pooled COVID-19 prevalence of 0.76% (95% CI 0.36% to 1.59%). The calculated PPV for this prevalence is 40.8%.
The pooled COVID-19 prevalence in asymptomatic patients tested preoperatively was 0.76%, with low corresponding PPV. Consequently, nearly three-quarters of postponed surgical procedures in asymptomatic preoperative patients may be FP. In the event of similar pandemics, modification of preoperative mandatory RT-PCR COVID-19 testing in asymptomatic patients may be considered.
COVID-19 患者可能无症状,并且能够在手术过程中传播 COVID-19,从而增加医疗保健的压力并降低 COVID-19 传播的控制。对于无症状手术患者是否应实施 COVID-19 的术前筛查,仍存在不确定性。因此,本研究旨在确定无症状患者中通过逆转录酶聚合酶链反应(RT-PCR)确诊的术前 COVID-19 的患病率。
系统评价和荟萃分析。
通过 2022 年 2 月 20 日检索 Pubmed 和 Embase 数据库。
所有包含术前无症状患者的 COVID-19 文章均被纳入。
两名独立的审查员提取数据并评估偏倚风险。采用荟萃分析确定 COVID-19 的患病率,置信区间为 95%。此外,还计算了术前无症状患者的估计阳性预测值(PPV)、阴性预测值、假阳性(FP)和假阴性。
共纳入 27 项研究,包含 27256 例无症状术前筛查患者,其中 431 例经 RT-PCR 检测 COVID-19 阳性。此外,荟萃分析显示 COVID-19 的总患病率为 0.76%(95% CI 0.36%至 1.59%)。计算得出的该患病率的 PPV 为 40.8%。
术前无症状患者的 COVID-19 总患病率为 0.76%,相应的 PPV 较低。因此,近四分之三的无症状术前患者推迟的手术可能是 FP。在发生类似大流行的情况下,可能需要考虑修改无症状患者术前强制性 RT-PCR COVID-19 检测。